Picture of HAMLET Pharma AB logo

HAMLET TO4 B HAMLET Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Hamlet Pharma Gets Patent Granted In Europe

Nov 17 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * NEUTRACEUTICAL PATENT GRANTED IN EUROPE
    * PATENT IS VALID UNTIL AUGUST 8, 2033

Source text for Eikon:  ID:nWkr8ZS72B 
Further company coverage:  HAMLET.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on HAMLET Pharma AB

See all news